An antiproliferative bioassay for interleukin-4

Journal of Immunological Methods

Volumn 189, Issue 1, 1996, Pages 129-135

  Page, Lisa A ^a   Topp, Max S ^b   Thorpe, Robin ^a   Mire Sluis, Anthony R ^a  

^a NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Bioassay; Cytokine quantification; IL 4

Indexed keywords

CYTOKINE; INTERLEUKIN 4;

ARTICLE; BIOASSAY; BLOOD LEVEL; CELL LINE; CELL PROLIFERATION; HUMAN; HUMAN CELL; LUNG CARCINOMA; PRIORITY JOURNAL;

EID: 0030067277     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/0022-1759(95)00245-6     Document Type: Article

References (43)

1. Banchereau, J. (1990) Human interleukin-4 and its receptor. In: R. Mertelsmann and F. Herrman (Eds.), Hematological Growth Factors in Clinical Applications. Marcel Dekker, New York, p. 433.
2. Bird, C., Wadhwa, M. and Thorpe, R. (1991) Development of immunoassays for human IL-3 and IL-4 some of which discriminate between different recombinant DNA derived molecules. Cytokine 3, 562.
3. Broxmeyer, H.E., Lu, L., Cooper, S., Rubin, B.Y., Gillis, S. and Williams, D.E. (1988) Synergistic effects of purified recombinant human and murine B-cell growth factor/IL-4 on colony formation in vivo by hematopoietic progenitor cells. J. Immunol. 141, 3852.
4. + TCR alpha beta+ T-cell clones derived early after allogeneic bone marrow transplantation. Scand. J. Immunol. 38, 65.
5. Callard, R.E. (1991) Immunoregulation by interleukin-4 in man. Br. J. Haematol. 78, 293.
6. Cornacoff, J.B., Gossett, K.A., Barbolt, T.A. and Dean, J.H. (1992) Preclinical evaluation of recombinant human interleukin-4. Toxicol. Lett. 64/65, 299.
7. +), soluble IL-2R and IL-4 with disease activity in SLE patients. Lupus 2, 257.
8. Custer, M.C. and Lotze, M.T. (1990) Rapid fluorescence assay for IL-4 detection in supernatants and serum. J. Immunol. Methods 128, 109.
9. Defrance, T., Fluckiger, A.C., Rossi, J.F., Magaud, J.P., Sotto, J.J. and Banchereau, J. (1992) Antiproliferative effects of interleukin-4 on freshly isolated non-Hodgkin malignant B-lymphoma cells. Blood 79, 990.
10. European Pharmacopoeia (1971) Statistical Evaluation of Biological Assays, 2, 441.
11. Giard, D.J., Aaronson, S.A., Todaro, G.J., Arnstein, P., Kersey, J.H., Dosik, H. and Parks, W.P. (1983) In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J. Natl. Cancer Inst. 51, 1417.
12. Golumbek, P.T., Lazenby, A.J., Levitsky, H.I., Jaffee, L.M., Karasuyama, H., Baker, M. and Pardoll, D.M. (1991) Treatment of established renal cancer by tumour cells engineered to secrete interleukin-4. Science 254, 713.
13. Hart, P.H., Vitti, D.R., Burgess, G.A., Whitty, G.A., Picolli, D.S. and Hamilton, J.A. (1989) Potential anti-inflammatory effects of IL-4. Suppression of human monocyte tumor necrosis factor, interleukin-1 and prostaglandin E2. Proc. Natl. Acad. Sci. USA 68, 3803.
14. Howard, M., Farrar, J., Hilfiker, M., Johnson, B., Takatsu, K., Hamaoka, T. and Paul, W.E. (1982) Identification of a T cell derived B cell growth factor distinct from interleukin 2. J. Exp. Med. 155, 914.
15. Hu-Li, J., Ohara, J., Watson, C., Tsang, W. and Paul, W.E. (1989) Derivation of a T cell line that is highly responsive to IL-4 and IL-2 (CT.4R) and of an IL-2 hyporesponsive mutant of that line (CT.4S). J. Immunol. 142, 800.
16. Kitamura, T., Tange, T., Terasawa, T., Chiba, S., Kuwaki, T., Miyagawa, K., Piao, Y.-F., Miyazono, K., Urabe, A. and Takaku, F. (1989) Establishment and characterisation of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin. J. Cell. Physiol. 140, 323.
17. Komatsu, N., Nakauchi, H., Miwa, A., Ishihara, T., Eguchi, M., Moroi, M., Okada, M., Sato, Y., Wada, H., Yawata, Y., Suda, T. and Miura, Y. (1991) Establishment and characterization of a human leukemic cell line with megakaryocytic features: Dependency on granulocyte-macrophage colony-stimulating factor, interleukin-3, or erythropoietin for growth and survival. Cancer Res. 51, 341.
18. Margolin, K., Aronson, F.R., Sznol, M., Atkins, M.B., Gucalp, R., Fisher, R.I., Sunderland, M., Doroshow, J.H., M.L., E., Mier, J.W., Dutcher, J.P., Gaynor, E.R. and Weiss, G.R. (1994) Phase II studies of recombinant human interleukin-4 in advanced renal cancer and malignant melanoma. J. Immunol. 147.
19. Matsumoto, K., Taki, F., Miura, M., Matsuzaki, M. and Takagi, K. (1994) Serum levels of soluble IL-2R, IL-4 and soluble Fc ∈ RII in adult bronchial asthma. Chest 105.
20. Needleman, B.W., Wigley, F.M. and Stair, R.W. (1992) Interleukin-1, interleukin-2, interleukin-4, interleukin-6, tumour necrosis factor α and interferon-γ levels in sera from patients with scleroderma. Arthritis Rheum. 35, 67.
21. Ohara, J. (1988) Interleukin-4: Molecular structure and biochemical characteristics, biological function and receptor expression. Year Immunol. 5, 126.
22. Ohara, J., Coligan, J., Zoon, K., Maloy, W.L. and Paul, W.E. (1987) High-efficiency purification and chemical characterization of B cell stimulatory factor-1/interleukin-4. J. Immunol. 139, 1127.
23. Paul, W.E. (1991) Interleukin-4: A prototypic immunoregulatory lymphokine. J. Am. Soc. Haematol. 77, 1859.
24. Peschel, C., Paul, W.E., Ohara, J. and Green, I. (1987) Effects of B cell stimulatory factor-1/interleukin-4 on hematopoietic progenitor cells. Blood 70, 254.
25. Phillips, J.H., Nagler, A., Spits, H. and Lanier, L.L. (1992) Immunomodulating effects of IL-4 on human natural killer cells. In: H. Spits (Ed.), IL-4: Structure and Function. CRC Press, Ann Arbor, MI, p. 169.
26. Puri, R.K. and Siegel, J.P. (1993) Interleukin-4 and cancer therapy. Cancer Invest. 11, 473.
27. Ramsdell, F., Picha, K.S., Seaman, M.S. and Kennedy, M.K. (1994) TNF abrogates the response of the CT.4S cell line to IL-4. J. Immunol. Methods 167, 299.
28. Randall, L.A., Wadhwa, M., Thorpe, R. and Mire-Sluis, A.R. (1993) A novel sensitive bioassay for transforming growth factor-beta. J. Immunol. Methods 164, 61.
29. Renz, H., Jujo, K., Bradley, K.L., Domenico, J., Gelfand, F.W. and Leung, D.Y. (1992) Enhanced IL-4 production and IL-4 receptor expression in atopic dermatitis and their modulation by interferon-gamma. J. Invest. Dermatol. 99, 403.
30. Schwarting, R., Weite, K., Chiorazzi, N., Ralph, P., Lane, C.L., Long, C. and Wang, C.Y. (1985) Biochemical characterization and purification of human B cell stimulatory factor (BSF). Eur. J. Immunol. 15, 632.
31. Siegel, J.P. and Mostowski, H.S. (1990) A bioassay for the measurement of human interleukin-4. J. Immunol. Methods 132, 287.
32. Spits, H. (Ed.) (1992). IL-4: Structure and Function. CRC Press, Ann Arbor, MI.
33. Takahasi, T., Sasaki, Y., Hama, K., Furue, M. and Ishibashi, Y. (1992) Production of IL-4, IL-2, IFN-gamma and IFN-alpha by peripheral blood mononuclear cells of patients with atopic dermatitis. J. Dermatol. Sci. 3, 172.
34. Taylor, C.W., Grogan, T.M. and Salmon, S.E. (1990) Effects of interleukin-4 on the in vitro growth of human lymphoid and plasma cell neoplasms. Blood 75, 1114.
35. Toi, M., Bicknell, R. and Harris, A.L. (1992) Inhibition of colon and breast carcinoma cell growth by interleukin-4. Cancer Res. 52, 275.
36. Topp, M.S., Koenigsmann, M., Mire-Sluis, A., Oberberg, D., Eitelbach, F., von Marschall, Z., Notter, M., Reufi, B., Stein, H., Thiel, E. and Berdel, W.E. (1993) Recombinant human interleukin-4 inhibits growth of some human lung tumor cell lines in vitro and in vivo. Blood 82, 2837.
37. Topp, M.S., Papadimitriou, C.A., Eitelbach, F., Koenigsmann, M., Oelmann, E., Koehler, B., Oberberg, D., Reufi, B., Stein, H., Thiel, E. and Berdel, W.E. (1995a) Recombinant human interleukin-4 has antiproliferative activity on human tumor cell lines derived from epithelial and nonepithelial histologies. Cancer Res. 55, 2173.
38. Topp, M.S., Papadimitriou, C.A., Eitelbach, F., Oelmann, E., Kohler, B., Oberberg, D., v. Marschall, Z., Reufi, B., Stein, H., Winton, E.F., Thiel, E. and Berdel, W.E. (1995b) Antiproliferative effect of human Interleukin-4 in human cancer cell lines: studies on the mechanism. Leukemia Lymphoma, in press.
39. Tsu, C.L., Duckett, T., De Kernion, J.B. and Belldegrun, A.S. (1992) Modulation of tumor-infiltrating lymphocytes derived from human renal cell carcinoma by interleukin-4. J. Immunotherapy 12, 82.
40. Wadhwa, M., Dilger, P., Tubbs, J., Barrowcliffe, T., Mahon, B. and Thorpe, R. (1991) Mechanisms of inhibition of T cell IL-2 secretion by factor VIII concentrates. Br. J. Haematol. 82, 575.
41. Wadhwa, M., Dilger, P., Tubbs, J., Mire-Sluis, A., Barrowcliffe, T. and Thorpe, R. (1994) Identification of transforming growth factor β1 as a contaminant in factor VIII concentrates: a possible link with immunosuppressive effects in haemophiliacs. Blood 84, 2021.
42. Yokota, T., Arai, N., De Vries, J., Spits, H., Banchereau, J., Zlotnik, A., Rennick, D., Howard, M., Takebe, Y., F.L., M. and Arai, K. (1986) Molecular biology of interleukin-4 and interleukin-5 genes and biology of their products that stimulate B cells, T cells and hemopoietic cells. Immunol. Rev. 102, 137.
43. Yu, J.S., Wei, M.X., Chiocca, E.A., Martuza, R.L. and Tepper, R.I. (1993) Treatment of glioma by engineered interleukin-4 secreting cells. Cancer Res. 53, 3125.